November 2026 — page 2
RideNow's Same-Store Sales Reverse After Clear Price Rollout
Third-quarter revenue was $244.3 million, down 13.1%, as adjusted EBITDA fell to $5.3 million and the company reported a larger net loss.
QuickLogic Sequential Revenue Falls After Prior Rise
Third-quarter continuing-operations revenue was $5.1 million, down 6.3% from the second quarter, as new-product sales slipped and GAAP net loss widened to $2.2 million.
D-Wave Locks CHIPS Deal as Remaining Obligations Hit $38.3 Million
Third-quarter revenue was $4.5 million, up 21%, as remaining performance obligations reached $38.3 million and a Commerce agreement opened access to up to $100 million of CHIPS funding.
Protalix Reaffirms 2026 Revenue Range After Chiesi Milestone
Nine-month revenue reached $75.6 million, including a $25.0 million Chiesi milestone, as third-quarter net income rose to $4.0 million.
PepGen Extends Cash Runway Into 2028 After FREEDOM2 Data
Cash, cash equivalents and marketable securities were $104.8 million as of September 30, 2026, and the company said that balance will fund operations into 2028.
Palladyne Raises Low End of 2026 Sales Outlook
Third-quarter revenue reached a record $8.6 million, and the company lifted the low end of 2026 guidance to $25 million while keeping the $27 million top end.
Palisade Bio Doses First Patient in Phase 2b Ulcerative Colitis Trial
Cash and cash equivalents were $113.6 million as of September 30, 2026, which the company said it believes will fund operations through Phase 2 readouts.
NCMI Completes Captivate Deal, Raises 2026 Savings Target
Third-quarter revenue was $61.4 million as Captivate closed Sept. 18, and the company now expects fourth-quarter revenue of $117.0 million to $124.0 million.
MaxCyte Lifts 2026 Revenue Guidance Excluding Akron Acquisition
Third-quarter revenue reached $10.2 million as the company raised full-year 2026 revenue guidance to at least $34.5 million, excluding the impact of the Akron acquisition, and agreed to buy Akron Bio for $151.8 million.
Mercury Reports Record First-Quarter Fiscal 2027 Revenue and Bookings
Fiscal 2027 first-quarter revenue was a record $253 million, while bookings reached $370 million, up 48.0% from a year earlier, and backlog approached $2.1 billion.
MasterCraft's Legacy Sales Rise 37% After Marine Products Close
Net sales were $154.1 million in the first three months of the transition period ended Oct. 4, 2026, and income from continuing operations was $12.1 million, or $0.50 a share.
908 Devices Raises Low End of 2026 Revenue Range
Third-quarter revenue reached $19.0 million, up 35% from a year earlier, and the company lifted the low end of its 2026 outlook to $68.5 million.
Liquidia Records $389.7 Million Settlement Charge
YUTREPIA net product sales reached $222.7 million in the third quarter as the company booked a $389.7 million litigation settlement charge.
KULR Product Sales Nearly Quadruple After Bitcoin Exit
Third-quarter continuing-operations revenue was $7.40 million, up 197% from a year earlier, as product sales reached $6.49 million.
Inhibikase Activates 79 of 180 Planned IMPROVE-PAH Sites
Cash, cash equivalents and marketable securities were $193.3 million after a $50 million RA Capital sale, and the company said that capital, assuming full and timely exercise of Series A and B warrants, will fund operations through the Part B topline readout.
Humacyte Doubles Symvess Sales After Commercial Rebuild
Third-quarter Symvess sales reached $1.0 million, and the company said it anticipates at least doubling that total in the fourth quarter.
GoPro Cannot File 10-Q, Flags Covenant Risk
The camera maker said it expects third-quarter net revenue of about $96 million and a 12.7% gross margin, and that financial statements will still show substantial doubt about its ability to continue as a going concern.
Gevo Lifts 2026 Adjusted EBITDA Outlook After Record Quarter
Third-quarter revenue hit a record $83 million, including about $29.4 million of Canadian CFR credits, as the company raised its 2026 Adjusted EBITDA target to greater than $90 million.
Electromed Extends Growth Streak as Revenue Pace Cools
Net revenues reached $18.7 million in the fiscal first quarter, up 10.6% from a year earlier, as operating income rose 30.7% to $3.5 million.
CoreWeave Raises 2026 Revenue Guidance After Operating Income Turns Positive
Third-quarter revenue reached $3.66 billion, up more than $1 billion sequentially, as the company lifted full-year sales to as much as $13.3 billion.
Corbus Starts Phase 3 Oropharyngeal Cancer Trial
The clinical-stage company dosed the first TEMPO-1 patient and reported 5% mean weight loss at 12 weeks on 60 mg CRB-913, with cash of $115.3 million expected to fund operations into 2028.
Core & Main Cuts Fiscal 2026 Ebitda Outlook
The specialty distributor now expects fiscal 2026 Adjusted EBITDA of $950 million to $960 million after preliminary third-quarter sales of $2.12 billion to $2.13 billion.
Black Rock Raises 2026 Opening Target to 40
Third-quarter revenue reached $66.8 million, up 29.7% from a year earlier, as same-store sales growth accelerated to 5.8%.
B&G Foods Restores Base Sales Growth and Lifts 2026 Outlook
Third-quarter net sales reached $459.8 million and full-year sales guidance moved to as much as $1.800 billion.
BridgeBio Oncology Extends Cash Runway Into 2029
Cash, cash equivalents and marketable securities stood at $315.3 million as of September 30, 2026, as the company reported a $34.2 million net loss for the third quarter.
Aviat Networks Updates Fiscal 2027 Revenue Outlook
The wireless transport maker booked more than $150 million in first-quarter orders, a 75% year-over-year rise, as it guided full-year revenue to $450 million to $475 million.
Ampco's Third-Quarter Sales Rise From Second Quarter
Net sales were $111.7 million as Air and Liquid Processing more than offset a U.K. plant closure in Forged and Cast products.
Archrock to Buy HiVolt Energy in $415 Million Cash Deal
The natural gas compression company will add a prime power microgrid platform and fund the $415 million upfront cash with its ABL facility.
NexGen narrows nine-month loss as debenture valuation improves
The uranium developer reported C$99.5 million in expenses for the nine months through September 2026, up from C$53.2 million a year earlier.
Greenfire's oil sales more than double as quarterly loss widens
The oil sands producer reported third-quarter bitumen output of 27,166 barrels a day and a C$21 million net loss.
Elemental Reports Quarterly Revenue Up 203%
Adjusted EBITDA reached US$16.6 million for the three months ended September 30, 2026.
Baytex Returns to Quarterly Profit as Revenue Rises
The energy producer's third-quarter production rose 5% as it returned to profit and increased its 2026 spending plan.
Tariffs and Middle East conflict lift inflation risk
Dauch (DCH) lifted its 2026 tariff-earnings hit and three regional banks tied credit and deposit risk to energy, tariffs and Middle East conflict.
Zentalis Extends Cash Runway Into First Half of 2028
Cash, cash equivalents and marketable securities reached $228.9 million after an August equity raise, while the company still targets a first-half 2027 DENALI topline readout.
ZipRecruiter Raises Full-Year Outlook After Revenue Beat
Third-quarter revenue was $124.4 million, above the $118 million to $124 million range, and the company now sees 4% to 5% full-year growth.
Whitehawk Starts Third ADC Trial, Widens Quarterly Loss
Cash, cash equivalents and short-term investments stood at $169.7 million as of September 30, 2026, with the company still anticipating funding into the second half of 2028.
Village Farms Cannabis Sales Hit Record as Gross Margin Falls
Cannabis net sales reached a record $55.0 million in the third quarter, while cannabis gross margin compressed to 48% from 55% a year earlier.
Ultralife Reverses Sales Decline as Backlog Hits Record
Third-quarter sales were $48.3 million, up 11.3% from a year earlier, and backlog reached a record $136.0 million.
Tonix TONMYA Sales Reach $15 Million After Medicare Deals
TONMYA net sales were about $15 million in the third quarter, up 37% from $11 million, as covered lives reached about 166 million.
Telos Raises Full-Year Outlook After Record Quarterly Profit
Third-quarter revenue of $55.2 million exceeded guidance as GAAP net income reached $4.4 million, the highest quarterly profit since the IPO.
SIGA Completes 19C Deliveries and Posts a Third-Quarter Loss
Product sales were $0.2 million in the three months ended September 30, 2026, after $37.9 million in the second quarter.
Somnigroup Revises 2026 Adjusted EPS Outlook After Leggett Close
The bedding company posted record third-quarter net sales of $2.35 billion and set full-year adjusted EPS at $2.85–$2.95.
Superior Group Tightens 2026 Sales and Adjusted Earnings Floors
Third-quarter net sales were $146.0 million, up 5% from a year earlier, as Healthcare Apparel swung to a Segment Adjusted EBITDA loss.
Repay Cuts Full-Year Normalized Organic Growth Outlook
Third-quarter revenue reached $153.4 million as Consumer Payments organic growth stalled and the company lowered normalized organic growth to 5%-6%.
Ranger Energy's Sequential Revenue Growth Reverses
Third-quarter revenue was $162.8 million and Adjusted EBITDA $20.1 million as activity and costs compressed earnings.
Quanterix Narrows 2026 Revenue Outlook After Sequential Gain
Third-quarter revenue was $35.0 million, up 6.3% from the second quarter, reversing a drop from $36.4 million in the first quarter.
Quantum Extends Sequential Sales Streak and Non-GAAP Profit
Fiscal second-quarter revenue reached $89.6 million, up 42.9% from a year earlier, as the company posted a second straight quarter of non-GAAP profit.
OraSure Reverses Two-Quarter Revenue Decline
Third-quarter net revenues reached $30.9 million, up 14% from a year earlier, as the company guided a faster 2027 growth pace.
Octave Specialty Group's Third-Quarter Loss Narrows
Adjusted EBITDA to shareholders was $3.3 million, and Insurance Distribution revenue rose 35% to $58.4 million.
OPAL Fuels Flags 2026 RNG Output Below Guidance
Third-quarter Adjusted EBITDA reached $26.7 million as the company said full-year results should sit at the lower end of its range.